Bold Therapeutics Achieves Enrollment Milestone in Phase 2 Trial of BOLD-100 for Advanced Colorectal Cancer #Canada #Vancouver #cancer_therapy #Bold_Therapeutics #BOLD-100
@newsen.bsky.social@newsen.bsky.social
@newsen.bsky.socialBold Therapeutics Achieves Enrollment Milestone in Phase 2 Trial of BOLD-100 for Advanced Colorectal Cancer #Canada #Vancouver #cancer_therapy #Bold_Therapeutics #BOLD-100